Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine

Retrieved on: 2021-12-03 11:31:42

Tags for this article:

Click the tags to see associated articles and topics

Sanofi's Origimm takeover acquires skin microbiome-targeting candidate for acne vaccine. View article details on hiswai:

Excerpt

Sanofi is to acquire Origimm Biotechnology in a move that gives the ... The program looks to support the human immune system in controlling P.

Article found on: www.cosmeticsdesign-europe.com